Patient Preferences and Information Gaps Underlying the Predominance of Hemodialysis in Türkiye: A Cross-Sectional Survey of 1908 Patients.

IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY
Fatma Betul Guzel, Melis Simsir, Necmi Eren, Sinan Kazan, Serdal Gok, Cansu Ulgen, Ertugrul Erken, Orcun Altunoren, Ozkan Gungor
{"title":"Patient Preferences and Information Gaps Underlying the Predominance of Hemodialysis in Türkiye: A Cross-Sectional Survey of 1908 Patients.","authors":"Fatma Betul Guzel, Melis Simsir, Necmi Eren, Sinan Kazan, Serdal Gok, Cansu Ulgen, Ertugrul Erken, Orcun Altunoren, Ozkan Gungor","doi":"10.61882/ijkd.3.03.8950","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Chronic kidney disease (CKD) is an important public health problem that is increasingly prevalent in Türkiye and the world. Patients with CKD should be informed about renal replacement therapy (RRT) before progression to end-stage kidney disease, and the most appropriate therapy should be selected for each patient. Although three different renal replacement therapy modalities exists, hemodialysis appears to be the most commonly chosen. In this study, we aimed to investigate why hemodialysis is often selected as the first-line therapy by patients.  Methods. In this cross-sectional, survey study; patients aged 18-80, who had been receiving treatment for more than three months and had initiated hemodialysis as their first RRT between 2010 and 2020 in Kahramanmaras, Kocaeli, and Istanbul were included. Patients completed a self-administered multiple-choice questionnarire.</p><p><strong>Results: </strong>A total of 1908 patients were included in the study. Before initiating hemodialysis, 61.1% of patients were under nephrology follow-up, whereas 38.3% had no prior follow-up. Alternative therapies to hemodialysis (peritoneal dialysis and kidney transplantation) were explained to 720 patients (37.7%), but not to 1,159 patients (60.7%). A total of 635 patients (33.3%) were asked about their treatment preferences, while 66% were not. After hemodialysis initiation, 937 patients (49.1%) were listed for cadaveric kidney transplantation, wheras 49.5% were not.</p><p><strong>Conclusion: </strong>Our study is a large, cross-sectional investigation of 1908 patients who selected hemodialysis as their initial RRT. The reasons patients choose hemodialysis over other modalities have long been debated, and substantial knowledge gaps among patients have been identified. We believe that nephrologist follow-up and patient information are important in choosing renal replacement therapy.</p>","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"20 3","pages":"157-162"},"PeriodicalIF":0.9000,"publicationDate":"2026-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian journal of kidney diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.61882/ijkd.3.03.8950","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Chronic kidney disease (CKD) is an important public health problem that is increasingly prevalent in Türkiye and the world. Patients with CKD should be informed about renal replacement therapy (RRT) before progression to end-stage kidney disease, and the most appropriate therapy should be selected for each patient. Although three different renal replacement therapy modalities exists, hemodialysis appears to be the most commonly chosen. In this study, we aimed to investigate why hemodialysis is often selected as the first-line therapy by patients.  Methods. In this cross-sectional, survey study; patients aged 18-80, who had been receiving treatment for more than three months and had initiated hemodialysis as their first RRT between 2010 and 2020 in Kahramanmaras, Kocaeli, and Istanbul were included. Patients completed a self-administered multiple-choice questionnarire.

Results: A total of 1908 patients were included in the study. Before initiating hemodialysis, 61.1% of patients were under nephrology follow-up, whereas 38.3% had no prior follow-up. Alternative therapies to hemodialysis (peritoneal dialysis and kidney transplantation) were explained to 720 patients (37.7%), but not to 1,159 patients (60.7%). A total of 635 patients (33.3%) were asked about their treatment preferences, while 66% were not. After hemodialysis initiation, 937 patients (49.1%) were listed for cadaveric kidney transplantation, wheras 49.5% were not.

Conclusion: Our study is a large, cross-sectional investigation of 1908 patients who selected hemodialysis as their initial RRT. The reasons patients choose hemodialysis over other modalities have long been debated, and substantial knowledge gaps among patients have been identified. We believe that nephrologist follow-up and patient information are important in choosing renal replacement therapy.

患者偏好和信息差距背后的优势血液透析在基耶:横断面调查1908例患者。
慢性肾脏疾病(CKD)是一个重要的公共卫生问题,在中国和世界范围内日益流行。CKD患者在进展为终末期肾病之前应告知肾脏替代治疗(RRT),并为每位患者选择最合适的治疗。虽然存在三种不同的肾脏替代治疗方式,但血液透析似乎是最常用的选择。在这项研究中,我们旨在探讨为什么血液透析经常被患者选择作为一线治疗。方法。在这个横断面调查研究中;在Kahramanmaras、Kocaeli和Istanbul,年龄在18-80岁,接受治疗超过3个月并在2010年至2020年期间开始血液透析作为第一次RRT的患者被纳入研究。患者完成了一份自我管理的多项选择问卷。结果:共纳入1908例患者。在开始血液透析前,61.1%的患者接受了肾内科随访,而38.3%的患者没有随访。有720例(37.7%)患者解释了血液透析的替代疗法(腹膜透析和肾移植),但有1159例(60.7%)患者没有解释。共有635名患者(33.3%)被问及他们的治疗偏好,而66%的患者没有。血液透析开始后,937例(49.1%)患者选择了尸体肾移植,49.5%的患者没有选择尸体肾移植。结论:我们的研究是一项大型的横断面调查,对1908名选择血液透析作为初始RRT的患者进行了调查。患者选择血液透析而不是其他方式的原因长期以来一直存在争议,并且已经确定患者之间存在实质性的知识差距。我们相信肾病专家的随访和患者的信息在选择肾脏替代疗法时是重要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Iranian journal of kidney diseases
Iranian journal of kidney diseases UROLOGY & NEPHROLOGY-
CiteScore
2.50
自引率
0.00%
发文量
43
审稿时长
6-12 weeks
期刊介绍: The Iranian Journal of Kidney Diseases (IJKD), a peer-reviewed journal in English, is the official publication of the Iranian Society of Nephrology. The aim of the IJKD is the worldwide reflection of the knowledge produced by the scientists and clinicians in nephrology. Published quarterly, the IJKD provides a new platform for advancement of the field. The journal’s objective is to serve as a focal point for debates and exchange of knowledge and experience among researchers in a global context. Original papers, case reports, and invited reviews on all aspects of the kidney diseases, hypertension, dialysis, and transplantation will be covered by the IJKD. Research on the basic science, clinical practice, and socio-economics of renal health are all welcomed by the editors of the journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书